Your browser doesn't support javascript.
loading
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides.
Wada, Fumito; Yamamoto, Tsuyoshi; Kobayashi, Tadayuki; Tachibana, Keisuke; Ito, Kosuke Ramon; Hamasaki, Mayumi; Kayaba, Yukina; Terada, Chisato; Yamayoshi, Asako; Obika, Satoshi; Harada-Shiba, Mariko.
Afiliación
  • Wada F; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan.
  • Yamamoto T; Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan.
  • Kobayashi T; Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Tachibana K; Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Ito KR; Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan.
  • Hamasaki M; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan.
  • Kayaba Y; Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan.
  • Terada C; Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Yamayoshi A; Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Obika S; Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Harada-Shiba M; Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan.
Mol Ther Nucleic Acids ; 26: 957-969, 2021 Dec 03.
Article en En | MEDLINE | ID: mdl-34760338

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Año: 2021 Tipo del documento: Article País de afiliación: Japón